Kathy Connell
Vermögen: 16 860 $ am 31.07.2026
Vermögen: 16 860 $ am 31.07.2026
Kathy Connell is the founder of Medicines Australia.
Current jobs include Non-Executive Director at Avecho Biotechnology Ltd. starting in 2024, Independent Non-Executive Director at Ceryvyn Therapeutics Ltd. starting in 2024, and Non-Executive Director at Proto Axiom Pty Ltd.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2026 | 2’000’000 ( 0.15% ) | 16 860 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AVECHO BIOTECHNOLOGY LIMITED | Direktor/Vorstandsmitglied | 26.04.2024 |
| CERYVYN THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 15.11.2024 |
Proto Axiom Pty Ltd.
Proto Axiom Pty Ltd. BiotechnologyHealth Technology Engages in drug development and medical equipment | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Avecho Biotechnology Ltd.
Avecho Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical and nutraceutical products | Health Technology |
Opthea Ltd.
Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Health Technology |
Proto Axiom Pty Ltd.
Proto Axiom Pty Ltd. BiotechnologyHealth Technology Engages in drug development and medical equipment | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen